CLINICAL_TRIALS
trial_result
· 2016-08-08
Clinical Trial Update: Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE) [Phase 4]
Summary
Phase 4 trial evaluating Lodotra (prednisone) for reducing morning stiffness duration in rheumatoid arthritis; results for the Mundipharma Korea Ltd-sponsored s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mundipharma Korea Ltd | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2016-08-08